Does the conventional cytogenetic risk profile still matter for prediction of venetoclax based treatment outcomes in AML? Editorial

  

Authors:	Bewersdorf, J. P.; Stone, R. M.; Tallman, M. S.; Stahl, M.
Title:	Does the conventional cytogenetic risk profile still matter for prediction of venetoclax based treatment outcomes in AML?
Journal Title:	Leukemia and Lymphoma
Volume:	62
Issue:	14
ISSN:	1042-8194
Publisher:	Taylor & Francis Group
Date Published:	2021-01-01
Start Page:	3318
End Page:	3319
Language:	English
DOI:	10.1080/10428194.2021.1986220
PUBMED:	34587866
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116315304&doi=10.1080%2f10428194.2021.1986220&partnerID=40&md5=2550b154848ab29250a7b6e02be99819
Notes:	Article -- Export Date: 3 January 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/191761